Moving from control to elimination of schistosomiasis in sub-Saharan Africa: time to change and adapt strategies

by Louis-Albert Tchuem Tchuenté, David Rollinson, J. Russell Stothard et al.
Infectious Diseases of Poverty, 2017 6:42 – Published: 20 February 2017

14 pp. 3.4 MB
http://idpjournal.biomedcentral.com/track/pdf/10.1186/s40249-017-0256-8?
site=idpjournal.biomedcentral.com

The major focus of preventive chemotherapy of schistosomiasis is delivery of praziquantel by mass drug administration to those shown to be, or presumed to be, at-risk of infection and disease. In some countries, regional progress may be uneven but in certain locations there are very real prospects to transition from control into interruption of transmission, and ultimately elimination. To manage this transition requires reconsideration of some of the currently deployed diagnostic tools used in surveillance and downward realignment of existing prevalence thresholds to trigger mass treatment.

(Visited 10 times, 1 visits today)
This entry was posted in Essential Medicines, General, Maternal & Child Health, Other Infectious Diseases. Bookmark the permalink.